Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 24;7(1):45.
doi: 10.1038/s41572-021-00278-x.

Haemophilia

Erik Berntorp  1   2 , Kathelijn Fischer  3 , Daniel P Hart  4   5 , Maria Elisa Mancuso  6 , David Stephensen  4   7 , Amy D Shapiro  8 , Victor Blanchette  9   10
Affiliations
Review

Haemophilia

Erik Berntorp et al. Nat Rev Dis Primers. .

Abstract

Haemophilia A and B are rare congenital, recessive X-linked disorders caused by lack or deficiency of clotting factor VIII (FVIII) or IX (FIX), respectively. The severity of the disease depends on the reduction of levels of FVIII or FIX, which are determined by the type of the causative mutation in the genes encoding the factors (F8 and F9, respectively). The hallmark clinical characteristic, especially in untreated severe forms, is bleeding (spontaneous or after trauma) into major joints such as ankles, knees and elbows, which can result in the development of arthropathy. Intracranial bleeds and bleeds into internal organs may be life-threatening. The median life expectancy was ~30 years until the 1960s, but improved understanding of the disorder and development of efficacious therapy based on prophylactic replacement of the missing factor has caused a paradigm shift, and today individuals with haemophilia can look forward to a virtually normal life expectancy and quality of life. Nevertheless, the potential development of inhibitory antibodies to infused factor is still a major hurdle to overcome in a substantial proportion of patients. Finally, gene therapy for both types of haemophilia has progressed remarkably and could soon become a reality.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Berntorp, E. & Shapiro, A. D. Modern haemophilia care. Lancet 379, 1447–1456 (2012). This is an easily accesible review of the fundamentals of modern haemophilia care. Still relevant despite publication year. - PubMed - PMC
    1. Biggs, R. & Macfarlane, R. G. Haemophilia and related conditions: a survey of 187 cases. Br. J. Haematol. 4, 1–27 (1958). - PubMed - PMC
    1. White, G. C. 2nd et al. Definitions in hemophilia. Thromb. Haemost. 85, 560 (2001). - PubMed - PMC
    1. Fischer, K. et al. Prospective observational cohort studies for studying rare diseases: the European PedNet Haemophilia Registry. Haemophilia 20, e280–e286 (2014). - PubMed - PMC
    1. WFH. Report on the Annual Global Survey 2019 http://www1.wfh.org/publications/files/pdf-1806.pdf (2020). The WFH Global Survey gives a good and up to date picture of demographics for haemophilia and other rare bleeding disorders worldwide.

LinkOut - more resources